10.1186/2228-5326-3-45

Emerging applications of nanoparticles for lung cancer diagnosis and therapy

PDF HTML
  • Uday Kumar Sukumar1,
  • Bharat Bhushan1,
  • Poornima Dubey1,
  • Ishita Matai1,
  • Abhay Sachdev1,
  • Gopinath Packirisamy*1,
  1. Nanobiotechnology Laboratory, Centre for Nanotechnology, Indian Institute of Technology Roorkee, Roorkee, Uttarakhand, 247667, IN
Cover Image

Published in Issue 2013-07-15

How to Cite

Sukumar, U. K., Bhushan, B., Dubey, P., Matai, I., Sachdev, A., & Packirisamy, G. (2013). Emerging applications of nanoparticles for lung cancer diagnosis and therapy. International Nano Letters, 3(1 (December 2013). https://doi.org/10.1186/2228-5326-3-45
Crossref
Scopus
Google Scholar
Europe PMC

PDF views: 111

HTML views: 30

Abstract

Abstract Lung cancer is by far the leading cause of cancer-related mortality worldwide, most of them being active tobacco smokers. Non small cell lung cancer accounts for around 85% to 90% of deaths, whereas the rest is contributed by small cell lung cancer. The extreme lethality of lung cancer arises due to lack of suitable diagnostic procedures for early detection of lung cancer and ineffective conventional therapeutic strategies. In course with desperate attempts to address these issues independently, a multifunctional nanotherapeutic or diagnostic system is being sought as a favorable solution. The manifestation of physiochemical properties of such nanoscale systems is tuned favorably to come up with a versatile cancer cell targeted diagnostic and therapeutic system. Apart from this, the aspect of being at nanoscale by itself confers the system with an advantage of passive accumulation at the site of tumor. This review provides a broad perspective of three major subclasses of such nanoscale therapeutic and diagnostic systems which include polymeric nanoparticles-based approaches, metal nanoparticles-based approaches, and bio-nanoparticles-based approaches. This review work also serves the purpose of gaining an insight into the pros and cons of each of these approaches with a prospective improvement in lung cancer therapeutics and diagnostics.

Keywords

  • Polymeric nanoparticles,
  • Metal nanoparticles,
  • Bio-nanoparticles,
  • Lung cancer,
  • Theranostics
PDF HTML

References

  1. Jemal et al. (2011) Global cancer statistics 61(2) (pp. 69-90) https://doi.org/10.3322/caac.20107
  2. Unknown ()
  3. Unknown ()
  4. Edwards et al. (1997) Large porous biodegradable particles for pulmonary drug delivery (pp. 1868-1871) https://doi.org/10.1126/science.276.5320.1868
  5. Unknown ()
  6. Longo et al. (2011) Approach to the patient with cancer (pp. 493-499) Mc Graw Hill
  7. Komaki and Cox (1994) Results
  8. Witschi (2001) A short history of lung cancer (pp. 4-6) https://doi.org/10.1093/toxsci/64.1.4
  9. Johnston (2001) O'Reilly
  10. Henschke et al. (2002) W.W. Norton and Company
  11. Mountain (1997) Revisions in the international system for staging lung cancer (pp. 1486-1487) https://doi.org/10.1378/chest.111.6.1486
  12. Lee et al. (2012) Self-assembled glycol chitosan nanogels containing palmityl-acylated exendin-4 peptide as a long-acting anti-diabetic inhalation system (pp. 728-734) https://doi.org/10.1016/j.jconrel.2012.05.029
  13. Bharali and Mousa (2010) Emerging nanomedicines for early cancer detection and improved treatment: current perspective and future promise (pp. 324-335) https://doi.org/10.1016/j.pharmthera.2010.07.007
  14. Mousa and Bharali (2011) Nanotechnology-based detection and targeted therapy in cancer: nano-bio paradigms and applications (pp. 2888-2903) https://doi.org/10.3390/cancers3032888
  15. Matsumura and Maeda (1986) A new concept for macromolecular therapeutics in cancer chemotherapy; mechanism of tumoritropic accumulation of proteins and the antitumour agent SMANCS (pp. 6387-6392)
  16. Lee et al. (2010) The characteristics, biodistribution, magnetic resonance imaging and biodegradability of superparamagnetic core-shell nanoparticles (pp. 1316-1324) https://doi.org/10.1016/j.biomaterials.2009.11.010
  17. Danhier et al. (2009) Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation (pp. 11-17) https://doi.org/10.1016/j.jconrel.2008.09.086
  18. Derakhshandeh et al. (2007) Encapsulation of 9-nitrocamptothecin, a novel anticancer drug, in biodegradable nanoparticles: factorial design, characterization and release kinetics (pp. 34-41) https://doi.org/10.1016/j.ejpb.2006.09.004
  19. Braden et al. (2009) Polymeric nanoparticles for sustained down-regulation of annexin A2 inhibit prostate tumor growth (pp. 2856-2865) https://doi.org/10.1166/jnn.2009.028
  20. Ogris and Wagner (2002) Tumor-targeted gene transfer with DNA polyplexes (pp. 85-95) https://doi.org/10.1023/A:1022988008131
  21. Nguyen et al. (2008) Effects of cell-penetrating peptides and PEGylation on transfection efficiency of polyethylenimine in mouse lungs (pp. 1236-1246) https://doi.org/10.1002/jgm.1255
  22. Koshkina et al. (2003) Biodistribution and pharmacokinetics of aerosol and intravenously administered DNA-polyethyleneimine complexes: optimization of pulmonary delivery and retention (pp. 249-254) https://doi.org/10.1016/S1525-0016(03)00177-1
  23. Gautam et al. (2002) Aerosol delivery of PEI-p53 complexes inhibits B16-F10 lung metastases through regulation of angiogenesis (pp. 28-36) https://doi.org/10.1038/sj.cgt.7700405
  24. Kimura et al. (2009) Nanoparticle-mediated delivery of nuclear factor κB decoy into lungs ameliorates monocrotaline-induced pulmonary arterial hypertension (pp. 877-883) https://doi.org/10.1161/HYPERTENSIONAHA.108.121418
  25. Ziady et al. (2003) Minimal toxicity of stabilized compacted DNA nanoparticles in the murine lung (pp. 948-956) https://doi.org/10.1016/j.ymthe.2003.09.002
  26. Ziady et al. (2003) Transfection of airway epithelium by stable PEGylated poly-l-lysine DNA nanoparticles in vivo (pp. 936-947) https://doi.org/10.1016/j.ymthe.2003.07.007
  27. Kaul and Amiji (2005) Tumor-targeted gene delivery using poly(ethylene glycol)-modified gelatin nanoparticles: in vitro and in vivo studies (pp. 951-961) https://doi.org/10.1007/s11095-005-4590-3
  28. Grenha et al. (2005) Microencapsulated chitosan nanoparticles for lung protein delivery (pp. 427-437) https://doi.org/10.1016/j.ejps.2005.04.009
  29. Issa et al. (2006) Targeted gene delivery with trisaccharide-substituted chitosan oligomers in vitro and after lung administration in vivo (pp. 103-112) https://doi.org/10.1016/j.jconrel.2006.06.029
  30. Gong et al. (2005) Gene transfer of vascular endothelial growth factor reduces bleomycin-induced pulmonary hypertension in immature rabbits (pp. 242-247) https://doi.org/10.1111/j.1442-200x.2005.02060.x
  31. Kaipel et al. (2008) Increased biological half-life of aerosolized liposomal recombinant human Cu/Zn superoxide dismutase in pigs (pp. 281-290) https://doi.org/10.1089/jamp.2007.0667
  32. Almeida and Souto (2007) Solid lipid nanoparticles as a drug delivery system for peptides and proteins (pp. 478-490) https://doi.org/10.1016/j.addr.2007.04.007
  33. Beck-Broichsitter et al. (2009) Pulmonary drug delivery with aerosolizable nanoparticles in an ex vivo lung model (pp. 169-178) https://doi.org/10.1016/j.ijpharm.2008.09.017
  34. Bivas-Benita et al. (2004) Cationic submicron emulsions for pulmonary DNA immunization (pp. 145-155) https://doi.org/10.1016/j.jconrel.2004.08.008
  35. Bouissou et al. (2006) The influence of surfactant on PLGA microsphere glass transition and water sorption: remodeling the surface morphology to attenuate the burst release (pp. 1295-1305) https://doi.org/10.1007/s11095-006-0180-2
  36. Jain (2000) The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices (pp. 2475-2490) https://doi.org/10.1016/S0142-9612(00)00115-0
  37. Ruhe et al. (2003) rhBMP-2 release from injectable PLGA/calcium-phosphate cement composites (pp. 75-81)
  38. Wu and Wang (2001) Synthesis, characterization, biodegradation, and drug delivery application of biodegradable lactic/glycolic acid polymers. Part II: biodegradation (pp. 21-34) https://doi.org/10.1163/156856201744425
  39. Sengupta et al. (2005) Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system (pp. 568-572) https://doi.org/10.1038/nature03794
  40. Benfer and Kissel (2012) Cellular uptake mechanism and knockdown activity of siRNA-loaded biodegradable DEAPA-PVA-g-PLGA nanoparticles 80(2) (pp. 247-256) https://doi.org/10.1016/j.ejpb.2011.10.021
  41. Nguyen et al. (2008) Fast degrading polyesters as siRNA nano-carriers for pulmonary gene therapy 132(3) (pp. 243-251) https://doi.org/10.1016/j.jconrel.2008.06.010
  42. Akbarzadeh et al. (2012) Preparation and in vitro evaluation of doxorubicin-loaded Fe3O4 magnetic nanoparticles modified with biocompatible copolymers (pp. 511-526)
  43. Okamoto et al. (2011) Chitosan-interferon-β gene complex powder for inhalation treatment of lung metastasis in mice 150(2) (pp. 187-195) https://doi.org/10.1016/j.jconrel.2010.12.006
  44. Okamoto et al. (2003) Pulmonary gene delivery by chitosan-pDNA complex powder prepared by a supercritical carbon dioxide process 92(2) (pp. 371-380) https://doi.org/10.1002/jps.10285
  45. Varkouhi et al. (2010) Gene silencing activity of siRNA polyplexes based on thiolated N,N,N-trimethylated chitosan 21(12) (pp. 2339-2346) https://doi.org/10.1021/bc1003789
  46. Lv et al. (2011) Porous quaternized chitosan nanoparticles containing paclitaxel nanocrystals improved therapeutic efficacy in non-small-cell lung cancer after oral administration 12(12) (pp. 4230-4239) https://doi.org/10.1021/bm2010774
  47. Ventura et al. (2011) Gemcitabine-loaded chitosan microspheres, characterization and biological in vitro evaluation 13(5) (pp. 799-807) https://doi.org/10.1007/s10544-011-9550-6
  48. Bharali et al. (2009) Nanoparticles and cancer therapy: a concise review with emphasis on dendrimers (pp. 1-7) https://doi.org/10.2217/17435889.4.1.1
  49. Kannan et al. (2004) Dynamics of cellular entry and drug delivery by dendritic polymers into human lung epithelial carcinoma cells 15(3) (pp. 311-330) https://doi.org/10.1163/156856204322977201
  50. Unknown ()
  51. Morgan et al. (2006) Dendrimer-encapsulated camptothecins: increased solubility, cellular uptake, and cellular retention affords enhanced anticancer activity in vitro 66(24) (pp. 11913-11921) https://doi.org/10.1158/0008-5472.CAN-06-2066
  52. Taratula et al. (2009) Surface-engineered targeted PPI dendrimer for efficient intracellular and intratumoral siRNA delivery 140(3) (pp. 284-293) https://doi.org/10.1016/j.jconrel.2009.06.019
  53. Rahbek et al. (2010) Bioresponsive hyperbranched polymers for siRNA and miRNA delivery 18(10) (pp. 812-820) https://doi.org/10.3109/1061186X.2010.527982
  54. Liu et al. (2010) Novel peptide-dendrimer conjugates as drug carriers for targeting nonsmall cell lung cancer 22(6) (pp. 59-69)
  55. Licciardi et al. (2012) PHEA-graft-polybutylmethacrylate copolymer microparticles for delivery of hydrophobic drugs 433(1–2) (pp. 16-24)
  56. Chiou et al. (2012) Cationic polyurethanes-short branch PEI-mediated delivery of Mir145 inhibited epithelial-mesenchymal trans differentiation and cancer stem-like properties and in lung adenocarcinoma 159(2) (pp. 240-250) https://doi.org/10.1016/j.jconrel.2012.01.014
  57. Zhou et al. (2011) Antitumoral efficacy by systemic delivery of heparin conjugated polyethylenimine-plasmid interleukin-15 complexes in murine models of lung metastasis 102(7) (pp. 1403-1409) https://doi.org/10.1111/j.1349-7006.2011.01956.x
  58. Hong et al. (2012) Suppression of lung cancer progression by biocompatible glycerol triacrylate-spermine-mediated delivery of shAkt1 (pp. 2293-2306)
  59. Guthi et al. (2010) MRI-visible micellar nanomedicine for targeted drug delivery to lung cancer cells 7(1) (pp. 32-40) https://doi.org/10.1021/mp9001393
  60. Tan et al. (2012) Perorally active nanomicellar formulation of quercetin in the treatment of lung cancer (pp. 651-661) https://doi.org/10.2217/nnm.11.151
  61. Craparo et al. (2011) Phospholipid-polyaspartamide micelles for pulmonary delivery of corticosteroids 406(1–2) (pp. 135-144)
  62. Kleemann et al. (2005) Nano-carriers for DNA delivery to the lung based upon a TAT-derived peptide covalently coupled to PEG-PEI 109(1–3) (pp. 299-316)
  63. Jere et al. (2008) Poly(b-amino ester) as a carrier for si/shRNA delivery in lung cancer cells (pp. 2535-2547) https://doi.org/10.1016/j.biomaterials.2008.02.018
  64. Liu et al. (2006) Novel polymeric microspheres containing norcantharidin for chemoembolization (pp. 35-41) https://doi.org/10.1016/j.jconrel.2006.08.022
  65. Fadel et al. (2010) Zinc phthalocyanine-loaded PLGA biodegradable nanoparticles for photodynamic therapy in tumor-bearing mice (pp. 283-292) https://doi.org/10.1007/s10103-009-0740-x
  66. Jain et al. (2012) Polyelectrolyte stabilized multilayered liposomes for oral delivery of paclitaxel 33(28) (pp. 6758-6768) https://doi.org/10.1016/j.biomaterials.2012.05.026
  67. Griset et al. (2009) Expansile nano- particles: synthesis, characterization, and in vivo efficacy of an acid-responsive polymeric drug delivery system (pp. 2469-2471) https://doi.org/10.1021/ja807416t
  68. Zubris et al. (2012) Hydrogels as intracellular depots for drug delivery 9(1) (pp. 196-200) https://doi.org/10.1021/mp200367s
  69. Minati et al. (2012) Multifunctional branched gold-carbon nanotube hybrid for cell imaging and drug delivery 28(45) (pp. 15900-15906) https://doi.org/10.1021/la303298u
  70. Murakami et al. (2012) Photodynamic and photothermal effects of semiconducting and metallic-enriched single-walled carbon nanotubes 134(43) (pp. 17862-17865) https://doi.org/10.1021/ja3079972
  71. Lodhi et al. (2013) Development and characterization of dexamethasone mesylate anchored on multi walled carbon nanotubes 21(1) (pp. 67-76) https://doi.org/10.3109/1061186X.2012.729213
  72. Arya et al. (2013) Combination of single walled carbon nanotubes/graphene oxide with paclitaxel: a reactive oxygen species mediated synergism for treatment of lung cancer (pp. 2818-2829) https://doi.org/10.1039/c3nr33190c
  73. Podesta et al. (2009) Antitumor activity and prolonged survival by carbon-nanotube-mediated therapeutic siRNA silencing in a human lung xenograft model 5(10) (pp. 1176-1185)
  74. Hou et al. (2009) The fabrication and characterization of dicalcium phosphate dihydrate-modified magnetic nanoparticles and their performance in hyperthermia processes in vitro (pp. 4700-4707) https://doi.org/10.1016/j.biomaterials.2009.05.018
  75. Tobin et al. (2013) Pegylated siRNA-loaded calcium phosphate nanoparticle-driven amplification of cancer cell internalization in vivo (pp. 2980-2990) https://doi.org/10.1016/j.biomaterials.2013.01.046
  76. Zhang et al. (2013) Systemic delivery of gemcitabine triphosphate via LCP nanoparticles for NSCLC and pancreatic cancer therapy 34(13) (pp. 3447-3458) https://doi.org/10.1016/j.biomaterials.2013.01.063
  77. Li et al. (2010) Biodegradable calcium phosphate nanoparticle with lipid coating for systemic siRNA delivery 142(3) (pp. 416-421) https://doi.org/10.1016/j.jconrel.2009.11.008
  78. Yang et al. (2012) Systemic delivery of siRNA via LCP nanoparticle efficiently inhibits lung metastasis 20(3) (pp. 609-615) https://doi.org/10.1038/mt.2011.270
  79. Li et al. (2012) Calcium phosphate nanoparticles with an asymmetric lipid bilayer coating for siRNA delivery to the tumor 158(1) (pp. 108-114) https://doi.org/10.1016/j.jconrel.2011.10.020
  80. Yang et al. (2008) Ex vivo magnetofection with magnetic nanoparticles: a novel platform for nonviral tissue engineering 32(3) (pp. 195-204) https://doi.org/10.1111/j.1525-1594.2007.00526.x
  81. Yu et al. (2008) Drug-loaded superparamagnetic iron oxide nanoparticles for combined cancer imaging and therapy in vivo 47(29) (pp. 5362-5365) https://doi.org/10.1002/anie.200800857
  82. Hu et al. (2008) A new photothermal therapeutic agent: core-free nanostructured Au x Ag1-x dendrites 14(10) (pp. 2956-2964) https://doi.org/10.1002/chem.200800114
  83. Cheng et al. (2009) Comparative efficiencies of photothermal destruction of malignant cells using antibody-coated silica@Au nanoshells, hollow Au/Ag nanospheres and Au nanorods 20(42) https://doi.org/10.1088/0957-4484/20/42/425104
  84. Chen et al. (2007) Methotrexate conjugated to gold nanoparticles inhibits tumor growth in a syngeneic lung tumor model (pp. 713-722) https://doi.org/10.1021/mp060132k
  85. Peng et al. (2009) Diagnosing lung cancer in exhaled breath using gold nanoparticles (pp. 669-673) https://doi.org/10.1038/nnano.2009.235
  86. Chon et al. (2009) Highly sensitive immunoassay of lung cancer marker carcinoembryonic antigen using surface-enhanced Raman scattering of hollow gold nanospheres (pp. 3029-3034) https://doi.org/10.1021/ac802722c
  87. Ho et al. (2010) Diagnostic detection of human lung cancer-associated antigen using a gold nanoparticle-based electrochemical immunosensor 82(14) (pp. 5944-5950) https://doi.org/10.1021/ac1001959
  88. He et al. (2009) Rapid identification and high sensitive detection of cancer cells on the gold nanoparticles interface by combined contact angle and electrochemical measurements 77(3) (pp. 1009-1014) https://doi.org/10.1016/j.talanta.2008.07.063
  89. Medley et al. (2008) Gold nanoparticle-based colorimetric assay for the direct detection of cancerous cells 80(4) (pp. 1067-1072) https://doi.org/10.1021/ac702037y
  90. Barash et al. (2012) Classification of lung cancer histology by gold nanoparticle sensors (pp. 580-589) https://doi.org/10.1016/j.nano.2011.10.001
  91. Yoon et al. (2006) Specific targeting, cell sorting, and bioimaging with smart magnetic silica core–shell nanomaterials (pp. 209-215) https://doi.org/10.1002/smll.200500360
  92. Zhang et al. (2010) Fluorescent metal nanoshell probe to detect single miRNA in lung cancer cell 82(11) (pp. 4464-4471) https://doi.org/10.1021/ac100241f
  93. Choi et al. (2009) Toxicological effects of inorganic nanoparticles on human lung cancer A549 cells (pp. 463-471) https://doi.org/10.1016/j.jinorgbio.2008.12.017
  94. Lizon (1999) Chemical toxicity of some actinides and lanthanides towards alveolar macrophages: an in vitro study (pp. 1459-1471) https://doi.org/10.1080/095530099139322
  95. Chen et al. (2005) Nano neodymium oxide induces massive vacuolization and autophagic cell death in non-small cell lung cancer NCI-H460 cells (pp. 52-60) https://doi.org/10.1016/j.bbrc.2005.09.018
  96. Carlson et al. (2008) Unique cellular interaction of silver nanoparticles: size-dependent generation of reactive oxygen species (pp. 13608-13619) https://doi.org/10.1021/jp712087m
  97. Gopinath et al. (2010) Signaling gene cascade in silver nanoparticle induced apoptosis (pp. 240-245) https://doi.org/10.1016/j.colsurfb.2010.01.033
  98. Stoehr et al. (2011) Shape matters: effects of silver nanospheres and wires on human alveolar epithelial cells https://doi.org/10.1186/1743-8977-8-36
  99. Valodkar et al. (2011) In vitro toxicity study of plant latex capped silver nanoparticles in human lung carcinoma cells (pp. 1723-1728) https://doi.org/10.1016/j.msec.2011.08.001
  100. Liu et al. (2007) Biocompatible and detectable carboxylated nanodiamond on human cell https://doi.org/10.1088/0957-4484/18/32/325102
  101. Liu et al. (2009) Endocytic carboxylated nanodiamond for the labeling and tracking of cell division and differentiation in cancer and stem cells (pp. 4249-4259) https://doi.org/10.1016/j.biomaterials.2009.04.056
  102. Liu et al. (2010) Covalent linkage of nanodiamond paclitaxel for drug delivery and cancer therapy https://doi.org/10.1088/0957-4484/21/31/315106
  103. Chen et al. (2010) Modification of magnetic silica/iron oxide nanocomposites with fluorescent polymethacrylic acid for cancer targeting and drug delivery (pp. 6422-6429) https://doi.org/10.1039/c0jm00320d
  104. Desoize (2004) Metals and metal compounds in cancer treatment (pp. 1529-1544)
  105. Rafique et al. (2010) Transition metal complexes as potential therapeutic Agents (pp. 38-45)
  106. Peng et al. (2011) Targeted delivery of cisplatin to lung cancer using ScFvEGFR-heparin-cisplatin 5(12) (pp. 9480-9493) https://doi.org/10.1021/nn202410f
  107. Chougule et al. (2011) Anticancer activity of noscapine, an opioid alkaloid in combination with cisplatin in human non-small cell lung cancer (pp. 271-282) https://doi.org/10.1016/j.lungcan.2010.06.002
  108. Vajpayee et al. (2011) Hexanuclear self-assembled arene-ruthenium nano-prismatic cages: potential anticancer agents (pp. 5184-5186) https://doi.org/10.1039/c1cc10167f
  109. Rizvi et al. (2008) Phase I/II trial of weekly intravenous 130 nm albumin-bound paclitaxel as initial chemotherapy in patients with stage IV non-small-cell lung cancer 26(4) (pp. 639-643) https://doi.org/10.1200/JCO.2007.10.8605
  110. Ibrahim et al. (2002) Phase I and pharmacokinetic study of ABI-007, a cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxel 8(5) (pp. 1038-1044)
  111. Green et al. (2006) Abraxane, a novel cremophor-free, albumin-bound particle form of paclitaxel for the treatment of advanced non-small-cell lung cancer 17(8) (pp. 1263-1268) https://doi.org/10.1093/annonc/mdl104
  112. Yang et al. (2010) 99mTc-hematoporphyrin linked albumin nanoparticles for lung cancer targeted photodynamic therapy and imaging (pp. 9042-9046) https://doi.org/10.1039/c0jm01544j
  113. Reynolds et al. (2009) Phase II trial of nanoparticle albumin-bound paclitaxel, carboplatin, and bevacizumab in first-line patients with advanced nonsquamous non-small cell lung cancer 4(12) (pp. 1537-1543) https://doi.org/10.1097/JTO.0b013e3181c0a2f4
  114. Socinski et al. (2012) Weekly nab-paclitaxel in combination with carboplatin versus solvent-based paclitaxel plus carboplatin as first-line therapy in patients with advanced non-small-cell lung cancer: final results of a phase III trial 30(17) (pp. 2055-2062) https://doi.org/10.1200/JCO.2011.39.5848
  115. Socinski et al. (2013) Safety and efficacy of weekly nab(R)-paclitaxel in combination with carboplatin as first-line therapy in elderly patients with advanced non-small-cell lung cancer (pp. 314-321)
  116. Li et al. (2012) Multifunctional ferritin cage nanostructures for fluorescence and MR imaging of tumor cells https://doi.org/10.1039/c1nr11132a
  117. Tseng et al. (2007) Development of gelatin nanoparticles with biotinylated EGF conjugation for lung cancer targeting 28(27) (pp. 3996-4005) https://doi.org/10.1016/j.biomaterials.2007.05.006
  118. Moschos et al. (2007) Lung delivery studies using siRNA conjugated to TAT(48–60) and penetratin reveal peptide induced reduction in gene expression and induction of innate immunity 18(5) (pp. 1450-1459) https://doi.org/10.1021/bc070077d
  119. Robertson et al. (2011) Engineered T4 viral nanoparticles for cellular imaging and flow cytometry 22(4) (pp. 595-604) https://doi.org/10.1021/bc100365j
  120. Kawabata et al. (2012) Intratracheal administration of a nanoparticle-based therapy with the angiotensin II type 2 receptor gene attenuates lung cancer growth 72(8) (pp. 2057-2067) https://doi.org/10.1158/0008-5472.CAN-11-3634
  121. Kim et al. (2012) Dual lectin-based size sorting strategy to enrich targeted N-glycopeptides by asymmetrical flow field-flow fractionation: profiling lung cancer biomarkers 84(12) (pp. 5343-5350) https://doi.org/10.1021/ac300772w
  122. Sham et al. (2004) Formulation and characterization of spray-dried powders containing nanoparticles for aerosol delivery to the lung 269(2) (pp. 457-467) https://doi.org/10.1016/j.ijpharm.2003.09.041
  123. Liu et al. (2011) Apoferritin-camouflaged Pt nanoparticles: surface effects on cellular uptake and cytotoxicity (pp. 7105-7110) https://doi.org/10.1039/c1jm10575b
  124. Liu et al. (2012) Apoferritin–CeO2 nano-truffle that has excellent artificial redox enzyme activity (pp. 3155-3157) https://doi.org/10.1039/c1cc15815e
  125. Zhang et al. (2010) Reducing stress on cells with apoferritin-encapsulated platinum nanoparticles (pp. 219-223) https://doi.org/10.1021/nl903313r
  126. Fan et al. (2011) Direct evidence for catalase and peroxidase activities of ferritin platinum nanoparticles (pp. 1611-1618) https://doi.org/10.1016/j.biomaterials.2010.11.004
  127. Mao et al. (2009) Virus-based chemical and biological sensing (pp. 6790-6810) https://doi.org/10.1002/anie.200900231
  128. Li et al. (2010) Viruses and their potential in bioimaging and biosensing applications (pp. 21-27) https://doi.org/10.1039/b911883g
  129. Lee and Wang (2006) Adaptations of nanoscale viruses and other protein cages for medical applications (pp. 137-149) https://doi.org/10.1016/j.nano.2006.07.009
  130. Steinmetz (2010) Viral nanoparticles as platforms for next generation therapeutics and imaging devices (pp. 634-641) https://doi.org/10.1016/j.nano.2010.04.005
  131. Beljanski and Hiscott (2012) The use of oncolytic viruses to overcome lung cancer drug Resistance (pp. 629-635) https://doi.org/10.1016/j.coviro.2012.07.006
  132. Robertson et al. (2011) Engineered T4 Viral nanoparticles for cellular imaging and flow cytometry (pp. 595-604) https://doi.org/10.1021/bc100365j
  133. MaHam et al. (2009) Protein-based nanomedicine platforms for drug delivery (pp. 1706-1721) https://doi.org/10.1002/smll.200801602
  134. Jahanshahi and Babaei (2008) Protein nanoparticle: a unique system as drug delivery vehicles (pp. 4926-4934)
  135. Brzoska et al. (2004) Incorporation of biodegradable nanoparticles into human airway epithelium cells-in vitro study of the suitability as a vehicle for drug or gene delivery in pulmonary diseases (pp. 562-570) https://doi.org/10.1016/j.bbrc.2004.04.067
  136. Wiley et al. (2009) Inducible bronchus-associated lymphoid tissue elicited by a protein cage nanoparticle enhances protection in mice against diverse respiratory viruses 4(9) https://doi.org/10.1371/journal.pone.0007142
  137. Müller et al. (2000) Solid lipid nanoparticles (SLN) for controlled drug delivery—a review of the state of the art 50(1) (pp. 161-177) https://doi.org/10.1016/S0939-6411(00)00087-4
  138. Barthelemy et al. (1999) Compritol 888 ATO: an innovative hot-melt coating agent for prolonged-release drug formulations 47(1) (pp. 87-90) https://doi.org/10.1016/S0939-6411(98)00088-5
  139. Baviskar et al. (2012) Modulation of drug release from nanocarriers loaded with a poorly water soluble drug (flurbiprofen) comprising natural waxes 67(8) (pp. 701-705)
  140. Mehnert and Mader (2001) Solid lipid nanoparticles: production, characterization and applications (pp. 165-196) https://doi.org/10.1016/S0169-409X(01)00105-3
  141. Muller et al. (2000) Large scale production of solid lipid nanoparticles (SLN) and nanosuspensions (DissoCubes) (pp. 359-376) Marcel Dekker
  142. Ma et al. (2009) Development of idarubicin and doxorubicin solid lipid nanoparticles to overcome Pgp–mediated multiple drug resistance in leukemia 5(2) (pp. 151-161) https://doi.org/10.1166/jbn.2009.1021
  143. Agu et al. (2001) The lung as a route for systemic delivery of therapeutic proteins and peptides (pp. 198-209) https://doi.org/10.1186/rr58
  144. Banga (2003) World Market Research Centre
  145. Choi et al. (2004) Low toxicity of cationic lipid-based emulsion for gene transfer (pp. 5893-5903) https://doi.org/10.1016/j.biomaterials.2004.01.031
  146. Zou et al. (1998) Effective treatment of early endobronchial cancer with regional administration of liposome-p53 complexes (pp. 1130-1137) https://doi.org/10.1093/jnci/90.15.1130
  147. Nassimi et al. (2009) Braun: a low cytotoxicity of solid lipid nanoparticles in in vitro and ex vivo lung models 21(Suppl 1) (pp. 104-109)